Zydus Life Science Intrinsic Value
Zydus Life Science intrinsic value. Zydus Life Science (ZYDUSLIFE) median intrinsic value is ₹1826.08 from 10 valuation models (range ₹341–₹2838), vs current price ₹1135.00 — +60.9% upside (Trading Below Calculated Value), margin of safety 37.8%. Compare with Zydus Life Science valuation methods to assess whether the stock is under or overvalued.
ZYDUSLIFE Valuation Methods Summary — DCF, Graham Number & P/E
Zydus Life Science intrinsic value across 10 models vs current price ₹1135.00 — upside/downside and value range per method. Read Zydus Life Science dividend policy for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1113.20 | ₹890.56 - ₹1335.84 | -1.9% | EPS: ₹50.60, Sector P/E: 22x |
| Book Value Method | asset | ₹2837.50 | ₹2553.75 - ₹3121.25 | +150.0% | Book Value/Share: ₹2928.91, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹2270.00 | ₹2043.00 - ₹2497.00 | +100.0% | Revenue/Share: ₹2997.62, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹2270.00 | ₹2043.00 - ₹2497.00 | +100.0% | EBITDA: ₹8556.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1606.96 | ₹1285.57 - ₹1928.35 | +41.6% | CF Growth: 0.2%, Discount: 15% |
| PEG Ratio Method | growth | ₹340.50 | ₹306.45 - ₹374.55 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹781.77 | ₹703.59 - ₹859.95 | -31.1% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹2270.00 | ₹2043.00 - ₹2497.00 | +100.0% | ROE: 18.1%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹1826.08 | ₹1643.47 - ₹2008.69 | +60.9% | EPS: ₹50.60, BVPS: ₹2928.91 |
| Dividend Yield Method | dividend | ₹340.50 | ₹306.45 - ₹374.55 | -70.0% | DPS: ₹1.00, Target Yield: 2.5% |
ZYDUSLIFE Intrinsic Value vs Market Price — All Valuation Models
Zydus Life Science fair value range ₹341–₹2838 vs current market price ₹1135.00 across 10 valuation models. For current market price and key ratios, visit Zydus Life Science share price today.
ZYDUSLIFE Intrinsic Value Analysis — Undervalued or Overvalued?
Zydus Life Science median intrinsic value ₹1826.08, current price ₹1135.00 — Trading Below Calculated Value by 60.9%, margin of safety 37.8%.
What is the intrinsic value of ZYDUSLIFE?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Zydus Life Science (ZYDUSLIFE) is ₹1826.08 (median value). With the current market price of ₹1135.00, this represents a +60.9% variance from our estimated fair value.
The valuation range spans from ₹340.50 to ₹2837.50, indicating ₹340.50 - ₹2837.50.
Is ZYDUSLIFE undervalued or overvalued?
Based on our multi-method analysis, Zydus Life Science (ZYDUSLIFE) appears to be trading below calculated value by approximately 60.9%.
ZYDUSLIFE Financial Health — Key Ratios vs Industry Benchmarks
Zydus Life Science financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 18.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.58x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ZYDUSLIFE Cash Flow Quality — Operating & Free Cash Flow
Zydus Life Science operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹2,117 Cr | ₹-1,831 Cr | Positive Operating Cash Flow | 6/10 |
| March 2025 | ₹6,781 Cr | ₹2,600 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹3,228 Cr | ₹2,482 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹2,689 Cr | ₹2,689 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹2,104 Cr | ₹2,104 Cr | Positive Free Cash Flow | 8/10 |